We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

117 hedge funds and large institutions have $387M invested in Pernix Therapeutics Holdings, Inc. in 2015 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 17

32% more call options, than puts

Call options by funds: $1.07M | Put options by funds: $814K

25% more capital invested

Capital invested by funds: $310M → $387M (+$76.8M)

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

21% more funds holding

Funds holding: 97117 (+20)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
117
Holders Change
+20
Holders Change %
+20.62%
% of All Funds
3.12%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
37
Increased
35
Reduced
29
Closed
17
Calls
$1.07M
Puts
$814K
Net Calls
+$261K
Net Calls Change
+$1.82M
Name Holding Trade Value Shares
Change
Change in
Stake
JAM
26
Jupiter Asset Management
United Kingdom
$3.84M +$7.24K +76 +0.2%
NIP
27
Nicholas Investment Partners
California
$3.83M +$3.42M +35,848 New
ACP
28
Acuta Capital Partners
California
$3.74M -$2.42M -25,408 -42%
Northern Trust
29
Northern Trust
Illinois
$3.66M +$21.7K +228 +0.7%
DCM
30
Driehaus Capital Management
Illinois
$3.21M +$804K +8,440 +39%
GTC
31
Ghost Tree Capital
New York
$2.67M +$2.38M +25,000 New
IA
32
Icon Advisers
Colorado
$2.62M +$2.33M +24,469 New
Charles Schwab
33
Charles Schwab
California
$2.52M +$1.79M +18,734 +384%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.44M +$64.4K +676 +3%
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$2.27M -$61.7K -647 -3%
Invesco
36
Invesco
Georgia
$1.98M +$1.68M +17,603 +1,845%
TC
37
TFS Capital
Pennsylvania
$1.96M +$1.75M +18,361 New
Geode Capital Management
38
Geode Capital Management
Massachusetts
$1.94M +$233K +2,440 +16%
Citadel Advisors
39
Citadel Advisors
Florida
$1.92M +$650K +6,817 +61%
TDC
40
Thompson Davis & Co
Virginia
$1.83M +$155K +1,631 +11%
NC
41
Northpointe Capital
Michigan
$1.81M +$642K +6,738 +66%
Two Sigma Investments
42
Two Sigma Investments
New York
$1.79M +$1.59M +16,729 New
NFA
43
Nationwide Fund Advisors
Ohio
$1.47M +$1.05M +10,992 +400%
AQR Capital Management
44
AQR Capital Management
Connecticut
$1.24M -$1.42M -14,920 -56%
TCIM
45
TIAA CREF Investment Management
New York
$1.2M -$1.02M -10,710 -49%
TI
46
Trexquant Investment
Connecticut
$1.19M +$1.06M +11,100 New
PP
47
PDT Partners
New York
$1.13M +$1.01M +10,594 New
JAM
48
JW Asset Management
Florida
$1.09M -$100K -1,049 -9%
BIM
49
BlackRock Investment Management
Delaware
$1.03M +$2.95K +31 +0.3%
Deutsche Bank
50
Deutsche Bank
Germany
$1.03M -$123K -1,292 -12%

PTX Hedge Fund Activity: Q1 2015 in Review

117 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q1 2015, worth a combined $387M — up 25% from $310M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PTX positions and 17 closed out — a net gain of 20 holders — while 35 added to existing stakes and 29 trimmed.

The largest buyer was RK Capital Management (Colorado), opening a new position worth an estimated $10.3M. The largest seller was Broadfin Capital, cutting an estimated $8.4M.

  • 117 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q1 2015, up from 97 in Q4 2014.
  • Funds reported $387M of Pernix Therapeutics Holdings, Inc. stock for Q1 2015, up 25% quarter-over-quarter.
  • 37 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q1 2015 and 17 closed out, a net change of +20 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q1 2015 was RK Capital Management (Colorado), an estimated $10.3M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q1 2015 was Broadfin Capital, an estimated $8.4M sold.

Based on aggregated 13F filings for Q1 2015.